The Effect of Interscalene Peripheral Nerve Block With 0.25% Bupivacaine vs 0.125% Bupivacaine on Lung Function

NCT01429584 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Diaphragm Paralysis

Interventions

DRUG: interscalene nerve block with 0.25% bupivacaine
DRUG: interscalene block with 0.125% bupivacaine

Sponsor

University of Utah